Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain
about
Differential influence of the 4F2 heavy chain and the protein related to b(0,+) amino acid transport on substrate affinity of the heteromeric b(0,+) amino acid transporterPrimary structure, genomic organization, and functional and electrogenic characteristics of human system N 1, a Na+- and H+-coupled glutamine transporterStructure, function, and regional distribution of the organic cation transporter OCT3 in the kidneyIRIP, a new ischemia/reperfusion-inducible protein that participates in the regulation of transporter activity.Membrane potential and pH-dependent accumulation of decynium-22 (1,1'-diethyl-2,2'-cyanine iodide) flourencence through OCT transporters in astrocytesDecynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depressionInteraction of organic cation transporter 3 (SLC22A3) and amphetamineUnfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyExpression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transportersEvidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brainTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Blood brain barrier: a challenge for effectual therapy of brain tumorsHuman placental Na+-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localizationVentricular choline transport: a role for organic cation transporter 2 expressed in choroid plexusCloning and functional characterization of a new subtype of the amino acid transport system NActivation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cellsImpaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient miceInfluence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraintCloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A.Structure of renal organic anion and cation transporters.Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) geneSmall molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.Transport of cimetidine by flounder and human renal organic anion transporter 1.Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia.Identification and characterization of a novel monoamine transporter in the human brain.Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.Expression and immunolocalization of the plasma membrane monoamine transporter in the brainOrganic cation transporter variation and response to smoking cessation therapiesGestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.The physiological role of drug transporters.Molecular and cellular physiology of renal organic cation and anion transport.Genetic Modulation of Neurocognitive Function in Glioma PatientsElectrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission
P2860
Q22254034-840375FC-2A03-4279-B021-EF12D556DFF4Q22254138-3E8933E7-45F9-4DC7-9395-09053D1C8D26Q24290163-65D3E285-6C08-4760-B4C8-909185CDC98FQ24307952-C6912EFA-70C8-445F-9D60-AB30A4368040Q24595515-1C782B78-2AE9-452C-B424-C479B2C52077Q24611123-6F17A314-BA7C-4AC9-843F-8A9E3D3BED8AQ24620591-633EFDF8-3067-451B-91F1-85108781AA73Q24658095-F0259B7C-4E3D-44E8-A39D-6A050CE26D67Q24673055-2CF96665-670A-47D6-874C-612DFC9470D3Q24673439-D5004108-CDEC-4868-957F-7705DB06ACB1Q24678282-A3E434DD-E950-4B98-8A2A-97B552250AE5Q27690256-8749E1BA-6904-4A61-8D67-8E9568CCFB7EQ28081947-C55D0706-B25A-4253-BA71-838DD22D586DQ28376106-16FF34E2-4E8D-4018-8639-74C451CE26EEQ28566394-C6A3553A-D543-49C0-8CEB-F10BCEEB470AQ28577577-508CE0BA-97DE-40CD-9D06-8DD8E1609A03Q28583028-12BE63C3-4BB4-4F53-BECE-3A89C7C8B1C0Q28588462-6D1F5DAB-8A5A-4110-8DEC-F0C739084855Q30443535-9E17F848-1C3D-45D5-9087-AE69472661C0Q30627964-51B8C2C6-7CCF-4BDD-A15D-1FBE2B960D4DQ33584577-07E7CFED-2B10-4C9F-BE4F-682D5640F680Q33714593-019DA3F3-9CC1-49E6-9E37-EAD4A879D025Q33780097-A56C6F94-ACE9-490C-8B27-1DE772520C56Q33896651-F0608301-FE48-415F-BBF0-04A9DC8885EFQ33932614-F7E825F6-2332-4DBB-9A23-33F93360FEF9Q33969200-BEBA498B-FE11-40A4-9424-1ABDC08C5BFAQ33985125-8B0F1969-BB25-4D16-A58E-EB66631A29F7Q34158797-0C572464-FF93-4166-9507-639853293CD5Q34344833-B43FEC39-717B-4BF8-859B-00E6D58D55FDQ34353039-86D3E537-FD2B-4348-8FFB-D1E2B0AB7EAEQ34359911-05D40D8E-5477-4875-B917-C36B10E32BACQ34570018-87A2EE00-E6B6-4D1C-8692-3ACBD75F228AQ34615851-F3B4D970-2439-4C6E-92DF-FF7BD931732AQ34974830-6A235175-6FFE-434B-AA76-7E779076D5D2Q35187893-54AF1426-9983-461D-BF69-176C668C7EFBQ35563701-33921DBC-77A1-47F3-B078-172F2C6012F2Q35842999-7C5914BC-89E0-4130-8C23-FC6813D5FE04Q35862672-4701B4AA-FE72-4DAD-BA43-2378A3FEA42CQ35996455-8EC7906B-AB44-4B8F-A0D8-7E490431FCDEQ36052518-4E7B6E10-51E9-4AE7-9C3B-F43376A9A9D6
P2860
Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain
description
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1998
@ast
im Dezember 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/12/04)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/12/04)
@nl
наукова стаття, опублікована в грудні 1998
@uk
name
Identity of the organic cation ...... f the transporter in the brain
@ast
Identity of the organic cation ...... f the transporter in the brain
@en
Identity of the organic cation ...... f the transporter in the brain
@nl
type
label
Identity of the organic cation ...... f the transporter in the brain
@ast
Identity of the organic cation ...... f the transporter in the brain
@en
Identity of the organic cation ...... f the transporter in the brain
@nl
prefLabel
Identity of the organic cation ...... f the transporter in the brain
@ast
Identity of the organic cation ...... f the transporter in the brain
@en
Identity of the organic cation ...... f the transporter in the brain
@nl
P2093
P2860
P3181
P356
P1476
Identity of the organic cation ...... f the transporter in the brain
@en
P2093
F. H. Leibach
S. J. Conway
V. Ganapathy
P2860
P304
32776–32786
P3181
P356
10.1074/JBC.273.49.32776
P407
P577
1998-12-04T00:00:00Z